Ann: Inhibition of SARS-CoV-2 by MPL in Human Respiratory Cells, page-60

Certainly, another step forward.

This may [will?] be good for people, in the last quarter of 2021. That's why I again say, it's NOT that we treat "Covid 19" it's the TYPE of lung [ARDS] disease our technology may be able to treat, the Covid-19 horse has long bolted, so far as PAA is concerned, it's similar conditions, EVERY Year, that MPL may help - that's the important thing we need to know - NOT "Covid-19" specifically!

Money EVERY Year, from a range of diseases, that can impact like Covid-19 does, is way more profitable than going after "Covid-19" specifically, it's simply a good test target. But others will get to the Covid-19 dance, well before PAA does.